Published in Virchows Arch on February 01, 2000
Characterization of alterations in diabetic myocardial tissue using high resolution MRI. Int J Cardiovasc Imaging (2005) 1.78
Low-voltage-activated ("T-Type") calcium channels in review. J Bioenerg Biomembr (2003) 1.06
Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels. J Bioenerg Biomembr (2003) 0.91
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor. Br J Pharmacol (2001) 0.90
Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies. Virchows Arch (2005) 0.80
Eps15 Homology Domain-containing Protein 3 Regulates Cardiac T-type Ca2+ Channel Targeting and Function in the Atria. J Biol Chem (2015) 0.76
Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med (1998) 7.34
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension (1992) 3.14
The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J (1992) 2.97
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2007) 2.91
The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest (1995) 2.35
Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol (1985) (1992) 2.24
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev (1995) 1.91
The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia. Proc Natl Acad Sci U S A (2001) 1.82
Biglycan is required for adaptive remodeling after myocardial infarction. Circulation (2008) 1.72
Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature (1984) 1.66
Cardiac angiosarcoma: case report and review of the literature. Z Kardiol (2005) 1.65
Hypertension caused by chronic intermittent hypoxia--influence of chemoreceptors and sympathetic nervous system. J Hypertens (1997) 1.62
Biosynthesis of antinutritional alkaloids in solanaceous crops is mediated by clustered genes. Science (2013) 1.60
Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension (1994) 1.56
Implementation of semi-automated cloning and prokaryotic expression screening: the impact of SPINE. Acta Crystallogr D Biol Crystallogr (2006) 1.56
"Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci U S A (1985) 1.56
AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension (1998) 1.54
The Mdm2 oncoprotein interacts with the cell fate regulator Numb. Mol Cell Biol (1998) 1.53
Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats. Cardiovasc Res (1998) 1.45
Histological and ultrastructural study of corneal tunnel incisions using diamond and steel keratomes. J Cataract Refract Surg (1998) 1.44
Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus alpha-toxin. Crit Care Med (2001) 1.43
Alpha atrial natriuretic peptide concentrations in plasma of children with congenital heart and pulmonary diseases. Br Med J (Clin Res Ed) (1985) 1.40
Repression of c-fos and c-jun gene expression is not part of AT2 receptor coupled signal transduction. J Mol Med (Berl) (1998) 1.39
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension (1992) 1.37
Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol Psychiatry (2006) 1.30
Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor. Cancer (1987) 1.27
Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke (1999) 1.23
Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science (1983) 1.17
Human acute pancreatitis: its pathogenesis in the light of immunocytochemical and ultrastructural findings in acinar cells. Virchows Arch A Pathol Anat Histopathol (1986) 1.17
The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene (1994) 1.15
Expression of the bcl-2 gene in mouse B lymphocytic cell lines is differentiation stage specific. Eur J Immunol (1987) 1.14
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol (1996) 1.13
Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation (2000) 1.12
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol (2001) 1.12
Recognition and management of overweight and obesity in primary care in Germany. Int J Obes Relat Metab Disord (2004) 1.09
The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions. Atherosclerosis (1997) 1.09
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. Proc Natl Acad Sci U S A (2000) 1.09
SPINE bioinformatics and data-management aspects of high-throughput structural biology. Acta Crystallogr D Biol Crystallogr (2006) 1.08
High-protein nutrition during pregnancy and lactation programs blood pressure, food efficiency, and body weight of the offspring in a sex-dependent manner. Am J Physiol Regul Integr Comp Physiol (2006) 1.08
AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J Pharmacol Exp Ther (2001) 1.08
Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology (1983) 1.07
Effect of repetitive icv injections of ANG II on c-Fos and AT(1)-receptor expression in the rat brain. Am J Physiol Regul Integr Comp Physiol (2001) 1.06
The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers. J Hum Hypertens (2002) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol (1999) 1.05
Significance of autofluorescence for the optical demarcation of field cancerisation in the upper aerodigestive tract. Acta Otolaryngol (1997) 1.03
The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med (1998) 1.01
Converting-enzyme in the choroid plexus, brain, and kidney: immunocytochemical and biochemical studies in rats. Neurosci Lett (1981) 1.01
Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension (1995) 1.01
Components of the renin-angiotensin system in the cerebrospinal fluid of rats and dogs with special consideration of the origin and the fate of angiotensin II. Neuroendocrinology (1980) 1.00
Catecholamine excretion in "idiopathic" edema: decreased dopamine excretion, a pathogenic factor? J Clin Endocrinol Metab (1977) 1.00
Indirect autofluorescence laryngoscopy in the diagnosis of laryngeal cancer and its precursor lesions. Eur Arch Otorhinolaryngol (2003) 0.99
Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins. Hypertension (1989) 0.98
Angiotensin peptides and inducible transcription factors. J Mol Med (Berl) (1999) 0.98
[Determination of the activity of peptidases and amino acid aryl amidases (author's transl)]. J Clin Chem Clin Biochem (1976) 0.98
Expression of autoimmune disease-related antigens by cells of the immune system. J Neurosci Res (1998) 0.98
Psychiatric sequelae to term birth and induced early and late abortion: a longitudinal study. Fam Plann Perspect (1973) 0.98
Angiotensin-converting enzyme in non-neoplastic kidney diseases. Kidney Int (1999) 0.97
Autoregulation of actin synthesis in hepatocytes by transcriptional and posttranscriptional mechanisms. Eur J Biochem (1995) 0.97
[Malignant angiosarcoma of the right atrium in pregnancy. Diagnostic and therapeutic problems]. Herz (1994) 0.96
Cellular distribution of endothelin-converting enzyme-1 in human tissues. J Histochem Cytochem (1999) 0.96
Tissue-specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction. Endocrinology (2000) 0.96
Measurement and characterization of angiotensin peptides in plasma. Clin Chem (1988) 0.96
Gabaergic stimulation inhibits central actions of angiotensin II: pressor responses, drinking and release of vasopressin. Eur J Pharmacol (1983) 0.95
Angiotensin and its AT2 receptor: new insights into an old system. Regul Pept (2001) 0.95
Evidence for the presence of enkephalins in the heart. Life Sci (1983) 0.95
Rat porphobilinogen deaminase gene: a pseudogene-free internal standard for laser-assisted cell picking. Biotechniques (1999) 0.95
Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1985) 0.95
The intrarenal renin-angiotensin-system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat. Klin Wochenschr (1982) 0.95
Modulation of autonomic nervous system adjustments to heat stress by central ANG II receptor antagonism. Am J Physiol (1994) 0.95
Physiological and pharmacological implications of AT1 versus AT2 receptors. Kidney Int Suppl (1998) 0.95
Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves. Brain Res Mol Brain Res (1998) 0.94
Determining the origins and the structural aberrations of small marker chromosomes in two cases of 45,X/46,X, + mar by use of chromosome-specific DNA probes. Am J Med Genet (1990) 0.94
Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens (1987) 0.94
Real-time tissue elastography versus FibroScan for noninvasive assessment of liver fibrosis in chronic liver disease. Ultraschall Med (2009) 0.94
Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol (2005) 0.94
Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther (1992) 0.94
Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor. Brain Res Mol Brain Res (1998) 0.93
Role of the kidney in primary hypertension: a renal transplantation study in rats. Am J Physiol (1990) 0.93
Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol (1985) 0.93
Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. Clin Sci (Lond) (1988) 0.93
Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins. J Card Fail (1997) 0.93
Central tachykinins: mediators of defence reaction and stress reactions. Can J Physiol Pharmacol (1995) 0.93
[Aim, design and methods of the "Hypertension and diabetes screening and awareness" -- (HYDRA) study]. Fortschr Med Orig (2003) 0.92
Converting enzyme inhibition in kinin-deficient brown Norway rats. Hypertension (1990) 0.92
Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat. Br J Pharmacol (1992) 0.92
Release and regulation of atrial natriuretic peptide (ANP). Eur Heart J (1987) 0.92
Immunostaining for cell picking and real-time mRNA quantitation. Am J Pathol (2000) 0.91
Atherosclerosis: humoral and cellular factors of inflammation. Virchows Arch (2005) 0.91
Development of genetic hypertension. Is there a "critical phase"? Hypertension (1990) 0.91
Peptidolytic monoclonal antibody elicited by a neuropeptide. J Biol Chem (1992) 0.91
[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version]. Pneumologie (2011) 0.91
Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. J Pharmacol Exp Ther (1986) 0.90
Angiotensin II induces a complex activation of transcription factors in the rat brain: expression of Fos, Jun and Krox proteins. Neuroscience (1995) 0.90
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor. Br J Pharmacol (2001) 0.90